Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:02:07.425Z.
Calculation as of: 2026-10-06T18:02:07.425Z.
Quote observation: 2026-10-06T17:04:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 787788ea5c712995087b0511470a3bc1500b131fb4a88c1f5ff44ca2612ce4c8
EARNINGS YIELD
N/A
Market Cap
$51.23M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.19M
Earnings Yield
N/A
TTM Avg
64.71%
3Y Avg
64.71%
5Y Avg
64.71%
Market Cap
$52.39M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| eXoZymes, Inc. (EXOZ) | $51.42M | N/A | N/A | N/A | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.23M | N/A | N/A | N/A | N/A |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | N/A | 64.71% | 64.71% | 64.71% |
| biote Corp. (BTMD)vs › | $52.05M | 9.89% | 27.99% | 16.26% | 33.61% |
| Clene Inc. (CLNN)vs › | $50.66M | N/A | 8.45% | 8.45% | 8.45% |
| Envoy Medical, Inc. (COCH)vs › | $50.56M | N/A | 0.74% | 0.74% | 0.74% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $52.39M | N/A | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | N/A | N/A | N/A | N/A |
| Aldeyra The (ALDX)vs › | $53.02M | N/A | 64.30% | 64.30% | 64.30% |
| ImageneBio Inc (IMA)vs › | $53.24M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
